NMPA Approval

Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray

Approval Number

国药准字H20223778

Company长风药业股份有限公司

Registration Date

November 1, 2022

Drug Information

Generic Name

氮䓬斯汀氟替卡松鼻喷雾剂

Dosage Form

鼻用制剂

Strength

每瓶120喷，每喷含盐酸氮䓬斯汀137μg和丙酸氟替卡松50μg

Drug Type

化学药品

Registration Date

November 1, 2022

Company Information

Applicant Company

Company Name长风药业股份有限公司

Company Address

苏州相城经济开发区湖村荡路16号

Manufacturing Company

Company Name长风药业股份有限公司

Company Address

苏州相城经济开发区湖村荡路16号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

氮䓬斯汀氟替卡松鼻喷雾剂 - NMPA 批准文号 | MedPath